Literature DB >> 27894765

Outcome in adults with anorectal malformations in relation to modern classification - Which patients do we need to follow beyond childhood?

Johan Danielson1, Urban Karlbom2, Wilhelm Graf2, Tomas Wester3.   

Abstract

BACKGROUND/
PURPOSE: Knowledge about the functional outcome in adults with anorectal malformations is essential to organize structured transition to adult care for this patient group. The aim of this study was to investigate the functional outcome and quality of life in adults with anorectal malformations characterized according to the Krickenbeck classification.
METHODS: Of 256 patients diagnosed with anorectal malformations at our institution in 1961-1993, 203 patients could be traced and were invited to participate in the study. One hundred and thirty-six patients replied (67%) and were compared with one hundred and thirty-six population based sex and age-matched controls. Patients and controls were evaluated with both a validated questionnaire as well as a study-specific questionnaire to assess bowel function. SF-36 was used for quality of life. Outcome in nine incontinence-related parameters, 10 constipation-related, 6 urogenital function-related, and 13 quality of life parameters were assessed in the patients and compared to the outcome of controls as well as to the type of anorectal malformations according to the Krickenbeck classification.
RESULTS: The ARM-patients had an inferior outcome (P<0.05) for all incontinence parameters, 8 of 10 parameters for constipation, 2 of 6 for urogenital function and 7 of 13 quality of life parameters. Patients with rectobulbar and vestibular fistulas had the worst statistical outcome but patients with cloaca and rectoprostatic/bladder-neck fistula had worse outcome in absolute numbers. Forty-four patients (32%) reported incontinence of stool at least once a week and 16 (12%) had a permanent colostomy.
CONCLUSIONS: The functional outcome and quality of life in adults with anorectal malformations are closely related to the type of malformation. A large proportion of the patients have persistent fecal incontinence, constipation and sexual problems that have a negative influence on their quality of life. Structured multidisciplinary follow-up of adults with anorectal malformations by pediatric and colorectal surgeons, as well as urologists and gynecologists is therefore advocated.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anorectal malformations; Functional outcome; Long term outcome; Quality of life; Sexual outcome; Transition to adult care

Mesh:

Year:  2016        PMID: 27894765     DOI: 10.1016/j.jpedsurg.2016.10.051

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Understanding of the transition to adult healthcare services among individuals with VACTERL association in Sweden: A qualitative study.

Authors:  Ann-Marie Kassa; Gunn Engvall; Michaela Dellenmark Blom; Helene Engstrand Lilja
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

2.  Quality of life and functional outcome in Swedish children with low anorectal malformations: a follow-up study.

Authors:  Helena Wigander; Margret Nisell; Björn Frenckner; Tomas Wester; Ulf Brodin; Maria Öjmyr-Joelsson
Journal:  Pediatr Surg Int       Date:  2019-02-07       Impact factor: 1.827

3.  Controlled outcome of Hirschsprung's disease beyond adolescence: a single center experience.

Authors:  Elisabet Gustafson; Therese Larsson; Johan Danielson
Journal:  Pediatr Surg Int       Date:  2018-11-20       Impact factor: 1.827

4.  Accuracy of pre-operative fistula diagnostics in anorectal malformations.

Authors:  Louise Tofft; Martin Salö; Einar Arnbjörnsson; Pernilla Stenström
Journal:  BMC Pediatr       Date:  2021-06-16       Impact factor: 2.125

5.  Transitional health care for patients with Hirschsprung disease and anorectal malformations.

Authors:  M J Witvliet; N Petersen; E Ekkerman; C Sleeboom; E van Heurn; A F W van der Steeg
Journal:  Tech Coloproctol       Date:  2017-07-03       Impact factor: 3.781

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.